Supporting SMEs during COVID-19: The case for targeted equity injections

Econ Lett. 2022 Oct:219:110717. doi: 10.1016/j.econlet.2022.110717. Epub 2022 Jul 26.

Abstract

We analyze the potential role of equity injections in addressing solvency risks among small and medium-sized enterprises (SMEs) after the COVID-19 crisis. Building on firm-level balance sheet projections for a sample of European economies, we simulate selected policy interventions and find that equity injections are quite effective at dampening the rise in insolvencies. Cost effectiveness requires careful targeting, however; under an illustrative scenario, leaving aside any costs arising from imperfect information and implementation, the cost of a program targeting only those SMEs worth saving is just a tenth of the cost of an untargeted approach directed to all insolvent firms. Overall, our paper provides a case for governments to rely more on targeted equity injections in responding to major shocks that trigger mass solvency risks.

Keywords: Bankruptcy; COVID-19; Equity injections; Insolvency; SMEs; Small and medium-sized enterprises.